Global healthcare company Abbott announced the launch of its latest generation XIENCE Sierra everolimus-eluting coronary stent system in India. This launch comes after the stent system received regulatory approval from India's Central Drugs Standard Control Organisation (CDSCO) in February 2023. The XIENCE Sierra is part of Abbott's family of drug-eluting...
Abbott Launches Valve to Treat Aortic Stenosis in India
Global healthcare company Abbott announced the launch of its latest-generation transcatheter aortic valve implantation (TAVI) system, NavitorTM, making available the minimally invasive device for people in India with severe aortic stenosis who are at high or extreme surgical risk. Aortic stenosis is one of the most common and life-threatening heart...